Finecure pharmaceuticals is a finished-dose manufacturer based in India. It appears in 77 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), NAFDAC (NG) and ARCSA (EC). Its GMP standing is certified by CDSCO (India), FDA (GH) and NAFDAC (NG), among 4 authorities. Customs aggregates show $9.3M of exports covering 261 molecules to 14 destinations in 2025.
| Site | FDA FEI |
|---|---|
| Ahmedabad, India | Not on file |
| distt udhamsingh nagar, India | Not on file |
| UDHAMSINGH NAGAR, Nigeria | Not on file |
| Regulator | Filings | GMP certificates |
|---|---|---|
| DIGEMAPS (DO) | 43 | None |
| NAFDAC (NG) | 32 | 2 |
| ARCSA (EC) | 2 | None |
| CDSCO (India) | None | 5 |
| FDA (GH) | None | 2 |
| EMA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $996K | 8 |
| 2025 | Not reported | $9.3M | 14 |
| 2024 | Not reported | $6.1M | 14 |
| 2023 | Not reported | $6.4M | 10 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Finecure pharmaceuticals comes back tiered against every other supplier able to file there.
Start for free